glp-1 news oct 16 2025 Bispecific GLP-1/GLP-2 agonism in advanced type 2 diabetes: preclinical characterization and a randomized, double-blind, placebo-controlled phase I trial Looming GLP-1 drug patent expirations

On the contrary, new GLP-1RA prescriptions among those with obesity or relevant comorbid conditions without Type 2 diabetes doubled, with a notable uptick in medication use especially since 2020, Rezaie said

Key Benefits of Therapy Clinical applications of this antioxidant extend beyond aesthetics

These properties make L-carnitine an essential ingredient in weight management and cellulite treatment products

Obesity and T2D disrupt the balance between bone formation and resorption, leading to increased bone fragility and fracture risk

[Abstract] Cells

By far, the most common and damaging mistake our team sees is shaking the vial instead of gently swirling it